[EU]. Commission Implementing Regulation (EU) 2024/2781 regards the extension of the approval periods of the active substances 8-hydroxyquinoline, Aminopyralid, Azoxystrobin, Chlorantraniliprole, Fluroxypyr, Imazalil, Kresoxim-methyl, Metobromuron, Oxyfluorfen, Tefluthrin and Terbuthylazine in 31/10/2024.

On 31 October 2024, the European Union amending Implementing Regulation No 540/2011 as regards the extension of the approval periods of the active substances 8-hydroxyquinoline, Aminopyralid, Azoxystrobin, Chlorantraniliprole, Fluroxypyr, Imazalil, Kresoxim-methyl, Metobromuron, Oxyfluorfen, Tefluthrin and Terbuthylazine.

Active substances Expiration of approval Extension of Approval Expiration date
8-hydroxyquinoline   31/12/2024 31/12/2025
Aminopyralid 31/12/2024 31/05/2027
Azoxystrobin 31/12/2024 31/05/2027
Chlorantraniliprole 31/12/2024 31/05/2027
Fluroxypyr 31/12/2024 31/05/2027
Imazalil 31/12/2024 31/05/2027
Kresoxim-methyl 31/12/2024 31/05/2027
Metobromuron 31/12/2024 31/05/2027
Oxyfluorfen 31/12/2024 31/05/2027
Tefluthrin 31/12/2024 31/05/2027
Terbuthylazine 31/12/2024 31/05/2027

 

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

See attached file for details:  https://eur-lex.europa.eu/eli/reg_impl/2024/2781/oj


Share post:
Related news
Cookie Policy

We use cookies to improve website and your experience. You can change your preferences at any time. To learn more, check out our Cookie Policy.